A model of pulmonary toxoplasmosis in rats as potential impact on immune deficient diseases

  • Mohey A. Hassanain
  • Nawal A. Hassanain
  • Raafat M. Shaapan
Original Article
  • 7 Downloads

Abstract

Toxoplasma gondii is an obligate intracellular zoonotic protozoan. Pulmonary involvement is common in immunocompromised hosts but rarely occurs in immunocompetent ones. Rat pulmonary involvement could be considered as a good representative model for study of human toxoplasmosis infection to either acute toxoplasmosis, chronic toxoplasmosis, or disseminated toxoplasmosis in human immunodeficiency virus (HIV) patients. Forty Swiss-Webster rats were divided into four groups each ten rats: group 1, non-infected and untreated (normal); group 2, acute infected non-treated; and groups 3 and 4, chronic infected non-treated and corticosteroid treated respectively. Lung tissue and blood samples were taken during acute and chronic stages for parasitological and histopathological study and serological assay. Acute and chronic states revealed the presence of viable toxoplasma tachyzoites and bradyzoites in lung tissue respectively. Serological assay showed different results in acute and chronic infections. The histopathological changes in acute rat group showed that per alveolar septa has been swollen due to swelling of the pneumocystis type I and II and the lining cells of the alveoli became low cuboidal in shape. The histopathological changes in chronic untreated rat group showed that the majority of alveolar walls were thickened due to swelling of the alveolar epithelial cells and mononuclear inflammatory cells and the bronchioles due to hyperplasia of its lining epithelium. Some of the blood vessel wall contained large number of chronic Toxoplasma cysts and surrounded by mononuclear cells. While chronic corticosteroid-treated rat group showed perivascular and alveolar edema with congested per alveolar blood capillaries and alveolar edema with compensatory emphysema of some others. The study concluded that toxoplasmosis is a great of interest, serious, and often a life-threatening disease in immune-deficient patients and sometimes in immunocompetent ones. Pulmonary toxoplasmosis should be considered in the differential diagnosis in potentially HIV-infected patients with respiratory symptoms and bilateral pulmonary infiltrates. Early diagnosis and initiating specific good therapy is essential.

Keywords

Toxoplasma gondii Pulmonary toxoplasmosis HIV Immune deficiency 

Notes

Compliance with ethical standards

Ethical approval

Ethical clearance and approval were obtained from the National Research Centre ethics Committee. Approval permission and written consents were obtained from all the participants in the study before collecting the data, and all had the right to withdraw from the study at any time without any explanation.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Ajzenberg D, Yera H, Marty P, Paris L, Dalle F, Menotti J, Aubert D, Franck J, Bessières MH, Quinio D, Pelloux H (2009) Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J Infec Dis 199(8):1155–1167CrossRefGoogle Scholar
  2. Barsoum RS (2006) Parasitic infections in transplant recipients. Nat Rev Nephrol 2(9):490CrossRefGoogle Scholar
  3. Benito N, Moreno A, Miro JM, Torres A (2012) Pulmonary infections in HIV-infected patients: an update in the 21st century. Euro Resp J 39(3):730–745CrossRefGoogle Scholar
  4. Carme B, Bissuel F, Ajzenberg D, Bouyne R, Aznar C, Demar M, Bichat S, Louve D, Bourbigot AM, Peneau C, Neron P (2002) Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana. J Clin Microbiol 40:4037–4044CrossRefPubMedPubMedCentralGoogle Scholar
  5. Culling CFA (1974) Hand book of histopathological and histochemical techniques. (Including Museum Techniques) 3rd Edition Butterworth and Co., London, pp. 73, 126 & 159Google Scholar
  6. de Souza Giassi K, Costa AN, Apanavicius A, Teixeira FB, Fernandes CJ, Helito AS, Kairalla RA (2014) Tomographic findings of acute pulmonary toxoplasmosis in immunocompetent patients. BMC Pulm Med 14(1):185CrossRefPubMedPubMedCentralGoogle Scholar
  7. Demar M, Hommel D, Djossou F, Peneau C, Boukhari R, Louvel D, Bourbigot AM, Nasser V, Ajzenberg D, Darde ML, Carme B (2012) Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana. Clin Microbiol Infect 18(7):E221–E231CrossRefPubMedGoogle Scholar
  8. Dubey JP (1997) Bradyzoite-induced murine toxoplasmosis: stage conversion, pathogenesis, and tissue cyst formation in mice fed bradvzoites of-different strains of T. gondii. J Eukaryot Microbiol 44:592–602CrossRefPubMedGoogle Scholar
  9. Dubey JP, Beattie CP (1988) Toxoplasmosis of animals and man. CRC Press, Boca Raton, pp 1–220Google Scholar
  10. Elfadaly HA, Hassanain MA, Shaapan RM, Hassanain NA, Barakat AM (2015) Corticosteroids opportunist higher Toxoplasma gondii brain cysts in latent infected mice. Int J Zool Res 11:169–176CrossRefGoogle Scholar
  11. Ferguson DJP (2004) Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host. Int J Parasitol 34:347–360CrossRefPubMedGoogle Scholar
  12. Glass CA (2010) Infectious disease guidelines. Family Practice Guidelines, p.365Google Scholar
  13. Köksal ZŞ, Yanik K, Bilgin K, Yılmaz EM, Hokelek M (2016) In vivo efficacy of drugs against Toxoplasma gondii combined with immunomodulatory. Jpn J Infect Dis 69:113–117CrossRefPubMedGoogle Scholar
  14. Leal FL, Cavazzana CL, de Andrade HF, Calisteo AJ, de Mendonca JS, Kallas EG (2007) Toxoplasma gondii pneumonia in immunocompetent subjects: case report and review. Clin Infect Dis 44:66–72CrossRefGoogle Scholar
  15. Oh YW, Effmann EL, Godwin JD (2000) Pulmonary infections in immunocompromised hosts: the importance of correlating the conventional radiologic appearance with the clinical setting. Radiology 217:647–656CrossRefPubMedGoogle Scholar
  16. Saadatnia G, Golkar M (2012) A review on human toxoplasmosis. Scand J Infect Dis 44(11):805–814CrossRefPubMedGoogle Scholar
  17. Shaapan RM, El-Nawawi FA, Tawfik MAA (2008) Sensitivity and specificity of various serological tests for the detection of Toxoplasma gondii infection in naturally infected sheep. Vet Parasitolo 153:359–362CrossRefGoogle Scholar
  18. Shaapan RM, Ghazy AA (2007) Isolation of Toxoplasma gondii from horse meat in Egypt. Pak J Biol Sci 10:174–177CrossRefPubMedGoogle Scholar
  19. Sharma SP, Dubey JP (1981) Quantitative survival of T. gondii tachyzoites and bradyzoites in pepsin and trypsin solutions. Am J Vet Res 42:128–130PubMedGoogle Scholar
  20. Zenner Z, Foulet A, Caudrelier Y, Darcy F, Gosselin B, Capron A, Delauw M (1999) Infection with Toxoplasma gondii RH and Prugniaud strain in mice, rats and nude rats: kinetics of infection in blood and tissues related to pathology in acute and chronic infection. Path Res Pract 195:475–485CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Zoonotic Diseases, National Research CenterGizaEgypt

Personalised recommendations